NERISONA

This brand name is authorized in Austria, Brazil, Germany, Japan

Active ingredients

The drug NERISONA contains one active pharmaceutical ingredient (API):

1 Diflucortolone UNII 1A63Z067C8 - DIFLUCORTOLONE VALERATE

Diflucortolone is a topically acting fluoridated corticosteroid which suppresses inflammation in inflammatory and allergic skin conditions and alleviates the subjective complaints such as itching, burning and pain. Read about Diflucortolone

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
D07AC06	Diflucortolone	D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07A Corticosteroids, plain → D07AC Corticosteroids, potent (group III)
Discover more medicines within D07AC06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 538912050015513, 538912050015613
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 01692661, 01692721, 04963505, 04963511, 08595352, 08595369, 08595381, 08595398, 17875369
Country: JP	医薬品医療機器総合機構	Identifier(s): 2646700M1163, 2646700N1150, 2646700N1169, 2646700Q1050